Tolvaptan Kit
RxNorm Crosswalk NDC 70748-242

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Tolvaptan (NDC 70748-242) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 10 unique RxNorm concepts. By anchoring Lupin Pharmaceuticals, Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

tolvaptan 45 MG Oral Tablet
(RxCUI 2044359)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

tolvaptan 60 MG Oral Tablet
(RxCUI 2044363)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

tolvaptan 90 MG Oral Tablet
(RxCUI 2044367)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

tolvaptan 60 MG / 30 MG Carton Pack
(RxCUI 2044966)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

tolvaptan 45 MG / 15 MG Carton Pack
(RxCUI 2044968)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

tolvaptan 90 MG / 30 MG Carton Pack
(RxCUI 2044970)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

tolvaptan 30 MG / 15 MG Carton Pack
(RxCUI 2274813)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

tolvaptan 15 MG / 15 MG Carton Pack
(RxCUI 2274815)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

tolvaptan 15 MG Oral Tablet
(RxCUI 2719335)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

tolvaptan 30 MG Oral Tablet
(RxCUI 2719337)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Understanding RxNorm Mapping for Tolvaptan

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 70748-242 to RxCUI 2044359, 2044363, 2044367, 2044966, 2044968, 2044970, 2274813, 2274815, 2719335, 2719337, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • GPCK Generic Pack: A standardized concept for a clinical kit containing multiple generic components.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.

* Please review the full disclaimer at the bottom of this page.